Distinct PKA and Epac compartmentalization in airway function and plasticity

Area of Science:

• Pulmonary Medicine
• Cellular Signaling
• Molecular Pharmacology

Background:

• Asthma and COPD are obstructive lung diseases involving airway obstruction, inflammation, and remodeling.
• Airway mesenchymal cells, including smooth muscle cells and fibroblasts, significantly contribute to disease pathogenesis.
• Current treatments target dynamic intracellular cyclic AMP (cAMP) signaling.

Purpose of the Study:

• To review current knowledge on cAMP signaling in airway mesenchymal cells in asthma and COPD.
• To highlight paradigm shifts in understanding compartmentalized cAMP signaling networks.
• To focus on the role of cAMP in airway fibroblast and smooth muscle cell function.

Main Methods:

• Review of existing literature on cAMP signaling pathways.
• Analysis of the role of cAMP effectors like AKAPs, PKA, Epac, 7TM receptors, and PDEs.
• Correlation of cAMP signaling perturbations with obstructive lung disease pathophysiology.

Main Results:

• cAMP signaling is complex, with compartmentalized networks playing a key role in airway mesenchymal cell function.
• Perturbations in these compartmentalized cAMP signaling pathways are linked to obstructive lung diseases.
• Identification of key cAMP-sensing multi-protein complexes involved in airway smooth muscle and fibroblast function.

Conclusions:

• Understanding cAMP dynamics and compartmentalization in the lung is essential.
• Targeting cAMP signaling networks presents a promising avenue for novel therapeutic interventions in chronic obstructive inflammatory diseases.
• Airway mesenchymal cells are central players, and their cAMP signaling is a critical therapeutic target.